DAIHAN Scientific Co., Ltd. (KOSDAQ:131220)
South Korea
· Delayed Price · Currency is KRW 4,420.00
0.00 (0.00%)
At close: Mar 24, 2025, 3:30 PM KST
DAIHAN Scientific Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 71,694 | 73,702 | 72,280 | 66,281 | 61,508 | Upgrade
|
| Other Revenue | -0 | - | - | - | - | Upgrade
|
| Revenue | 71,694 | 73,702 | 72,280 | 66,281 | 61,508 | Upgrade
|
| Revenue Growth (YoY) | -2.72% | 1.97% | 9.05% | 7.76% | 11.50% | Upgrade
|
| Cost of Revenue | 51,931 | 51,626 | 50,822 | 47,924 | 46,124 | Upgrade
|
| Gross Profit | 19,763 | 22,076 | 21,458 | 18,357 | 15,384 | Upgrade
|
| Selling, General & Admin | 13,096 | 13,435 | 12,316 | 10,721 | 9,922 | Upgrade
|
| Research & Development | 1,021 | 971.34 | 821.27 | 758.54 | 751.85 | Upgrade
|
| Other Operating Expenses | 343.33 | 335.52 | 253.68 | 243.08 | 244.95 | Upgrade
|
| Operating Expenses | 15,538 | 15,909 | 14,233 | 12,492 | 11,785 | Upgrade
|
| Operating Income | 4,225 | 6,167 | 7,224 | 5,865 | 3,600 | Upgrade
|
| Interest Expense | -95.56 | -151.32 | -53.51 | -42.46 | -45.7 | Upgrade
|
| Interest & Investment Income | 279.33 | 282.92 | 116.13 | 68.8 | 149.03 | Upgrade
|
| Earnings From Equity Investments | 16.4 | 4.68 | 22.11 | -12.27 | -565.88 | Upgrade
|
| Currency Exchange Gain (Loss) | -8.18 | -22.14 | 80.35 | 51.31 | -113.58 | Upgrade
|
| Other Non Operating Income (Expenses) | 116.6 | 172.93 | 160.1 | 204.58 | 182.03 | Upgrade
|
| EBT Excluding Unusual Items | 4,534 | 6,454 | 7,550 | 6,135 | 3,205 | Upgrade
|
| Gain (Loss) on Sale of Investments | -1.86 | -39.69 | - | - | -6.12 | Upgrade
|
| Gain (Loss) on Sale of Assets | 20.3 | 9.53 | -35.37 | -32.79 | -65.49 | Upgrade
|
| Asset Writedown | - | - | - | - | -57.35 | Upgrade
|
| Pretax Income | 4,552 | 6,424 | 7,514 | 6,102 | 3,076 | Upgrade
|
| Income Tax Expense | 626.66 | 1,202 | 1,272 | 1,087 | 324.55 | Upgrade
|
| Earnings From Continuing Operations | 3,926 | 5,222 | 6,242 | 5,015 | 2,752 | Upgrade
|
| Minority Interest in Earnings | -1,233 | -1,377 | -1,540 | -1,248 | -1,042 | Upgrade
|
| Net Income | 2,693 | 3,845 | 4,702 | 3,767 | 1,709 | Upgrade
|
| Net Income to Common | 2,693 | 3,845 | 4,702 | 3,767 | 1,709 | Upgrade
|
| Net Income Growth | -29.98% | -18.22% | 24.81% | 120.39% | 39.35% | Upgrade
|
| Shares Outstanding (Basic) | 7 | 7 | 7 | 7 | 7 | Upgrade
|
| Shares Outstanding (Diluted) | 7 | 7 | 7 | 7 | 7 | Upgrade
|
| Shares Change (YoY) | -1.50% | -1.04% | -0.48% | -0.20% | -3.33% | Upgrade
|
| EPS (Basic) | 386.00 | 543.00 | 657.10 | 523.98 | 237.27 | Upgrade
|
| EPS (Diluted) | 386.00 | 543.00 | 657.00 | 523.98 | 237.00 | Upgrade
|
| EPS Growth | -28.91% | -17.35% | 25.39% | 121.09% | 43.98% | Upgrade
|
| Free Cash Flow | 3,547 | 4,169 | 1,474 | 939.76 | 4,357 | Upgrade
|
| Free Cash Flow Per Share | 508.52 | 588.64 | 205.94 | 130.71 | 604.82 | Upgrade
|
| Dividend Per Share | - | - | 60.000 | 60.000 | 60.000 | Upgrade
|
| Gross Margin | 27.57% | 29.95% | 29.69% | 27.70% | 25.01% | Upgrade
|
| Operating Margin | 5.89% | 8.37% | 9.99% | 8.85% | 5.85% | Upgrade
|
| Profit Margin | 3.76% | 5.22% | 6.50% | 5.68% | 2.78% | Upgrade
|
| Free Cash Flow Margin | 4.95% | 5.66% | 2.04% | 1.42% | 7.08% | Upgrade
|
| EBITDA | 6,065 | 8,005 | 8,913 | 7,416 | 5,426 | Upgrade
|
| EBITDA Margin | 8.46% | 10.86% | 12.33% | 11.19% | 8.82% | Upgrade
|
| D&A For EBITDA | 1,840 | 1,838 | 1,689 | 1,552 | 1,827 | Upgrade
|
| EBIT | 4,225 | 6,167 | 7,224 | 5,865 | 3,600 | Upgrade
|
| EBIT Margin | 5.89% | 8.37% | 9.99% | 8.85% | 5.85% | Upgrade
|
| Effective Tax Rate | 13.77% | 18.71% | 16.93% | 17.81% | 10.55% | Upgrade
|
| Advertising Expenses | 209.09 | 227.43 | 54.41 | 49.86 | 118.41 | Upgrade
|
Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.